A team of investigators conducted a prospective cohort study to validate NGAL as a diagnostic and prognostic tool for AKI in cirrhosis within North America.
COVID-19 severity at hospital admission predicts complications even in young adults and those without pre-existing health conditions.
A study found no significant increased risks for death or major adverse cardiac events among infected patients with established chronic kidney disease or end-stage kidney disease.
But adverse effects, including hypotension, acute kidney injury, syncope, more frequent with intensive treatment in those at increased CV risk
Fewer sudden unexpected deaths occurred among patients who received early renal replacement therapy, investigators reported.
In a study comparing the effect of 9 oral nonsteroidal anti-inflammatory drugs on kidney function, ibuprofen conferred the lowest risk for incident eGFR less than 60 mL/min/1.73 m2 and an eGFR decline of 30% or greater.
The association of pulmonary hypertension with an increased risk for kidney failure in older adults with chronic kidney disease is a novel finding.
In a small study, 25% of adults with COVID-19 shed SARS-CoV-2 spike S1 protein in their urine at least once during the course of infection.
AKI seen in 14% of patients treated with antibiotic-loaded bone cement spacer after resection of periprosthetic joint infection
Learning how SARS-CoV-2 causes acute kidney injury could improve understanding of kidney physiology.